Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization
Bone Marrow Transplantation2012Vol. 47(12), pp. 1526–1529
Citations Over TimeTop 10% of 2012 papers
A I Chen, Tarunpreet Bains, S. Murray, R.K. Knight, Kelsea M. Shoop, Joseph Bubalo, Cedar Fowler, Susan Slater, Richard T. Maziarz
Related Papers
- → A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure(2012)33 cited
- → Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone(2010)20 cited
- → The current status in hematopoietic stem cell mobilization(2015)13 cited
- → Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor(2023)2 cited
- → On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone(2023)1 cited